PTC Therapeutics, Inc. (PTCT)
NASDAQ: PTCT · Real-Time Price · USD
71.91
+1.04 (1.47%)
Jun 9, 2026, 12:10 PM EDT - Market open
PTC Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citi | Citi | Buy Upgrades $108 | Buy | Upgrades | $108 | +50.19% | Jun 9, 2026 |
| Barclays | Barclays | Buy Reiterates $120 | Buy | Reiterates | $120 | +66.88% | May 28, 2026 |
| Jefferies | Jefferies | Buy Upgrades $76 → $85 | Buy | Upgrades | $76 → $85 | +18.20% | May 27, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 15, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Maintains $80 → $89 | Buy | Maintains | $80 → $89 | +23.77% | May 11, 2026 |
| RBC Capital | RBC Capital | Hold Maintains $81 → $82 | Hold | Maintains | $81 → $82 | +14.03% | May 8, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $92 → $94 | Buy | Maintains | $92 → $94 | +30.72% | May 8, 2026 |
| Raymond James | Raymond James | Buy Maintains $86 → $95 | Buy | Maintains | $86 → $95 | +32.11% | May 8, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.